Pharmala Biotech Holdings Inc. (CSE: MDMA)

Market Cap	23.48M
Revenue	n/a
Net Income	n/a
Shares Out	86.96M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,128
Average Volume	251,069
Open	0.270
Previous Close	0.270
Day's Range	0.255 - 0.270
52-Week Range	0.065 - 0.350
Beta	1.33
RSI	45.72
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA